DTL Is a Prognostic Biomarker and Promotes Bladder Cancer Progression through Regulating the AKT/mTOR axis

Figure 6

ssGSEA enrichment pathway-based DTL expression. (a–d) ssGSEA enrichment pathways in E-MTAB-4321, GSE13507, GSE32894, and TCGA datasets, respectively. (e) Venn diagram of the activated pathways in the four datasets. (f) Venn diagram of the suppressed pathways in the four datasets.

(a)

(b)

(c)

(d)

(e)

(f)